Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Narendra Modi
Lok Sabha Election 2024
Heatwave In India
Mumbai Mega Block
Maharashtra Lok Sabha Election
T20 World Cup 2024
All
News
Photos
Videos
Serum Institute Of India Private Ltd.
FOLLOW
Serum institute of india private ltd., Latest News
Serum Institute of India is an Indian biotechnology and biopharmaceuticals company. It is the world's largest vaccine manufacturer. It is located in the city of Pune, Maharashtra, India, and was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries.
Read More
National :
Slashed COVID-19 vaccine Covishield's prices to ensure more accessibility, reach, says SII's Adar Poonawalla
The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Se ...
National :
COVID vaccine: Covishield's price reduced from Rs 600 to Rs 225 per dose at pvt hospitals
Pune-based Serum Institute of India (SII) on Saturday announced that it has revised the price of its COVID vaccine Covishield for private hospitals from Rs 600 to Rs 225 per dose. ...
Health :
Covishield vaccine prices slashed for private hospitals
New Delhi, April 9 Ahead of the opening of the booster drive for all the 18 plus range, ... ...
National :
NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine -- Covovax for use for children and adults, on April 1, sources informed on Wednesday. ...
International :
Novovax' COVID-19 vaccine gets emergency use authorisation for adolescents between 12-18 yrs in India
Novavax on Tuesday announced the first emergency use authorization of its COVID-19 vaccine for adolescents falling in the age bracket of 12-18 years in India. ...
National :
DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax for children aged above 12 years
The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India's (SII) COVID-19 vaccine Covovax for adults and for children above the age of 12 years. ...
International :
Yet another milestone in fight against COVID-19: Adar Poonawalla on Covovax getting WHO's approval
After the Covovax vaccine got WHO's approval for emergency use, Chief Executive Officer of the Serum Institute of India Adar Poonawalla on Friday said that this is yet another milestone in our fight against COVID-19. ...
National :
Serum Institute's executive director Suresh Jadhav passes away
Serum Institute of India (SII) executive director Suresh Jadhav, who played an instrumental role in the field of vaccine manufacturing in India, passed away on Wednesday. ...
Previous Page
Next Page